Skip to content

Clinical trials

Completed Hepatitis C trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis C Status: Completed Country / region: Canada Clear all

109 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20042
20059
20064
20078
20083
20099
20106
201118
201210
20133
20147
201510
20164
20178
20181
20201
20212
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed109

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gilead Sciences16
Bristol-Myers Squibb14
AbbVie9
Vertex Pharmaceuticals Incorporated6
Janssen R&D Ireland5
Human Genome Sciences Inc.4
Boehringer Ingelheim3
Centre hospitalier de l'Université de Montréal (CHUM)3
Debiopharm International SA3
GlaxoSmithKline3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis C109
Hepatitis C, Chronic27
Fibrosis10
Hepatitis6
Acquired Immunodeficiency Syndrome5
Bronchiolitis Obliterans Syndrome4
Liver Cirrhosis4
HIV Infections3
Liver Diseases2
Virus Diseases2

Trials

Showing 1 to 25 of 109. Each trial links to its page on Pharma Observatory.

9 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.